世界の注射式標的治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Injectable Targeted Therapy Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4374
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、109ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、注射式標的治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（モノクローナル抗体、小分子、免疫毒素、その他）、用途別市場規模（病院、在宅医療、専門クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・注射式標的治療の市場動向
・企業の競争状況、市場シェア
・注射式標的治療の種類別市場規模と予測2016-2027（モノクローナル抗体、小分子、免疫毒素、その他）
・注射式標的治療の用途別市場規模と予測2016-2027（病院、在宅医療、専門クリニック、その他）
・注射式標的治療の北米市場規模2016-2027（アメリカ、カナダ）
・注射式標的治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・注射式標的治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・注射式標的治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・注射式標的治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Novartis、Sanofi、GSK、Bayer、Amgen、Merck、AbbiVie、AstraZeneca、Teva、Roche、Pfizer）
・結論

It is at the cellular and molecular level, designed for the treatment of well-defined carcinogenic sites, and designing corresponding therapeutic drugs. When drugs enter the body, they will specifically select carcinogenic sites to combine and act, causing tumor cells to die specifically, without Will affect the normal tissue cells around the tumor.

Market Analysis and Insights: Global Injectable Targeted Therapy Market
The global Injectable Targeted Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Injectable Targeted Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Injectable Targeted Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Injectable Targeted Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Injectable Targeted Therapy market.

Global Injectable Targeted Therapy Scope and Market Size
Injectable Targeted Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Injectable Targeted Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Monoclonal Antibodies
Small-Molecules
Immunotoxins
Others

Segment by Application
Hospitals
Homecare
Specialty Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Novartis
Sanofi
GSK
Bayer
Amgen
Merck
AbbiVie
AstraZeneca
Teva
Roche
Pfizer

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Injectable Targeted Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Monoclonal Antibodies
1.2.3 Small-Molecules
1.2.4 Immunotoxins
1.2.5 Others
1.3 Market by Application
1.3.1 Global Injectable Targeted Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Homecare
1.3.4 Specialty Clinics
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Injectable Targeted Therapy Market Perspective (2016-2027)
2.2 Injectable Targeted Therapy Growth Trends by Regions
2.2.1 Injectable Targeted Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Injectable Targeted Therapy Historic Market Share by Regions (2016-2021)
2.2.3 Injectable Targeted Therapy Forecasted Market Size by Regions (2022-2027)
2.3 Injectable Targeted Therapy Industry Dynamic
2.3.1 Injectable Targeted Therapy Market Trends
2.3.2 Injectable Targeted Therapy Market Drivers
2.3.3 Injectable Targeted Therapy Market Challenges
2.3.4 Injectable Targeted Therapy Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Injectable Targeted Therapy Players by Revenue
3.1.1 Global Top Injectable Targeted Therapy Players by Revenue (2016-2021)
3.1.2 Global Injectable Targeted Therapy Revenue Market Share by Players (2016-2021)
3.2 Global Injectable Targeted Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Injectable Targeted Therapy Revenue
3.4 Global Injectable Targeted Therapy Market Concentration Ratio
3.4.1 Global Injectable Targeted Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Injectable Targeted Therapy Revenue in 2020
3.5 Injectable Targeted Therapy Key Players Head office and Area Served
3.6 Key Players Injectable Targeted Therapy Product Solution and Service
3.7 Date of Enter into Injectable Targeted Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Injectable Targeted Therapy Breakdown Data by Type
4.1 Global Injectable Targeted Therapy Historic Market Size by Type (2016-2021)
4.2 Global Injectable Targeted Therapy Forecasted Market Size by Type (2022-2027)

5 Injectable Targeted Therapy Breakdown Data by Application
5.1 Global Injectable Targeted Therapy Historic Market Size by Application (2016-2021)
5.2 Global Injectable Targeted Therapy Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Injectable Targeted Therapy Market Size (2016-2027)
6.2 North America Injectable Targeted Therapy Market Size by Type
6.2.1 North America Injectable Targeted Therapy Market Size by Type (2016-2021)
6.2.2 North America Injectable Targeted Therapy Market Size by Type (2022-2027)
6.2.3 North America Injectable Targeted Therapy Market Size by Type (2016-2027)
6.3 North America Injectable Targeted Therapy Market Size by Application
6.3.1 North America Injectable Targeted Therapy Market Size by Application (2016-2021)
6.3.2 North America Injectable Targeted Therapy Market Size by Application (2022-2027)
6.3.3 North America Injectable Targeted Therapy Market Size by Application (2016-2027)
6.4 North America Injectable Targeted Therapy Market Size by Country
6.4.1 North America Injectable Targeted Therapy Market Size by Country (2016-2021)
6.4.2 North America Injectable Targeted Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Injectable Targeted Therapy Market Size (2016-2027)
7.2 Europe Injectable Targeted Therapy Market Size by Type
7.2.1 Europe Injectable Targeted Therapy Market Size by Type (2016-2021)
7.2.2 Europe Injectable Targeted Therapy Market Size by Type (2022-2027)
7.2.3 Europe Injectable Targeted Therapy Market Size by Type (2016-2027)
7.3 Europe Injectable Targeted Therapy Market Size by Application
7.3.1 Europe Injectable Targeted Therapy Market Size by Application (2016-2021)
7.3.2 Europe Injectable Targeted Therapy Market Size by Application (2022-2027)
7.3.3 Europe Injectable Targeted Therapy Market Size by Application (2016-2027)
7.4 Europe Injectable Targeted Therapy Market Size by Country
7.4.1 Europe Injectable Targeted Therapy Market Size by Country (2016-2021)
7.4.2 Europe Injectable Targeted Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Injectable Targeted Therapy Market Size (2016-2027)
8.2 Asia-Pacific Injectable Targeted Therapy Market Size by Type
8.2.1 Asia-Pacific Injectable Targeted Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Injectable Targeted Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Injectable Targeted Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Injectable Targeted Therapy Market Size by Application
8.3.1 Asia-Pacific Injectable Targeted Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Injectable Targeted Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Injectable Targeted Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Injectable Targeted Therapy Market Size by Region
8.4.1 Asia-Pacific Injectable Targeted Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Injectable Targeted Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Injectable Targeted Therapy Market Size (2016-2027)
9.2 Latin America Injectable Targeted Therapy Market Size by Type
9.2.1 Latin America Injectable Targeted Therapy Market Size by Type (2016-2021)
9.2.2 Latin America Injectable Targeted Therapy Market Size by Type (2022-2027)
9.2.3 Latin America Injectable Targeted Therapy Market Size by Type (2016-2027)
9.3 Latin America Injectable Targeted Therapy Market Size by Application
9.3.1 Latin America Injectable Targeted Therapy Market Size by Application (2016-2021)
9.3.2 Latin America Injectable Targeted Therapy Market Size by Application (2022-2027)
9.3.3 Latin America Injectable Targeted Therapy Market Size by Application (2016-2027)
9.4 Latin America Injectable Targeted Therapy Market Size by Country
9.4.1 Latin America Injectable Targeted Therapy Market Size by Country (2016-2021)
9.4.2 Latin America Injectable Targeted Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Injectable Targeted Therapy Market Size (2016-2027)
10.2 Middle East & Africa Injectable Targeted Therapy Market Size by Type
10.2.1 Middle East & Africa Injectable Targeted Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Injectable Targeted Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Injectable Targeted Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Injectable Targeted Therapy Market Size by Application
10.3.1 Middle East & Africa Injectable Targeted Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Injectable Targeted Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Injectable Targeted Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Injectable Targeted Therapy Market Size by Country
10.4.1 Middle East & Africa Injectable Targeted Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Injectable Targeted Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Injectable Targeted Therapy Introduction
11.1.4 Novartis Revenue in Injectable Targeted Therapy Business (2016-2021)
11.1.5 Novartis Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Injectable Targeted Therapy Introduction
11.2.4 Sanofi Revenue in Injectable Targeted Therapy Business (2016-2021)
11.2.5 Sanofi Recent Development
11.3 GSK
11.3.1 GSK Company Details
11.3.2 GSK Business Overview
11.3.3 GSK Injectable Targeted Therapy Introduction
11.3.4 GSK Revenue in Injectable Targeted Therapy Business (2016-2021)
11.3.5 GSK Recent Development
11.4 Bayer
11.4.1 Bayer Company Details
11.4.2 Bayer Business Overview
11.4.3 Bayer Injectable Targeted Therapy Introduction
11.4.4 Bayer Revenue in Injectable Targeted Therapy Business (2016-2021)
11.4.5 Bayer Recent Development
11.5 Amgen
11.5.1 Amgen Company Details
11.5.2 Amgen Business Overview
11.5.3 Amgen Injectable Targeted Therapy Introduction
11.5.4 Amgen Revenue in Injectable Targeted Therapy Business (2016-2021)
11.5.5 Amgen Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Injectable Targeted Therapy Introduction
11.6.4 Merck Revenue in Injectable Targeted Therapy Business (2016-2021)
11.6.5 Merck Recent Development
11.7 AbbiVie
11.7.1 AbbiVie Company Details
11.7.2 AbbiVie Business Overview
11.7.3 AbbiVie Injectable Targeted Therapy Introduction
11.7.4 AbbiVie Revenue in Injectable Targeted Therapy Business (2016-2021)
11.7.5 AbbiVie Recent Development
11.8 AstraZeneca
11.8.1 AstraZeneca Company Details
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Injectable Targeted Therapy Introduction
11.8.4 AstraZeneca Revenue in Injectable Targeted Therapy Business (2016-2021)
11.8.5 AstraZeneca Recent Development
11.9 Teva
11.9.1 Teva Company Details
11.9.2 Teva Business Overview
11.9.3 Teva Injectable Targeted Therapy Introduction
11.9.4 Teva Revenue in Injectable Targeted Therapy Business (2016-2021)
11.9.5 Teva Recent Development
11.10 Roche
11.10.1 Roche Company Details
11.10.2 Roche Business Overview
11.10.3 Roche Injectable Targeted Therapy Introduction
11.10.4 Roche Revenue in Injectable Targeted Therapy Business (2016-2021)
11.10.5 Roche Recent Development
11.11 Pfizer
11.11.1 Pfizer Company Details
11.11.2 Pfizer Business Overview
11.11.3 Pfizer Injectable Targeted Therapy Introduction
11.11.4 Pfizer Revenue in Injectable Targeted Therapy Business (2016-2021)
11.11.5 Pfizer Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Injectable Targeted Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Small-Molecules
Table 4. Key Players of Immunotoxins
Table 5. Key Players of Others
Table 6. Global Injectable Targeted Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Injectable Targeted Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Injectable Targeted Therapy Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Injectable Targeted Therapy Market Share by Regions (2016-2021)
Table 10. Global Injectable Targeted Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Injectable Targeted Therapy Market Share by Regions (2022-2027)
Table 12. Injectable Targeted Therapy Market Trends
Table 13. Injectable Targeted Therapy Market Drivers
Table 14. Injectable Targeted Therapy Market Challenges
Table 15. Injectable Targeted Therapy Market Restraints
Table 16. Global Injectable Targeted Therapy Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Injectable Targeted Therapy Market Share by Players (2016-2021)
Table 18. Global Top Injectable Targeted Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Injectable Targeted Therapy as of 2020)
Table 19. Ranking of Global Top Injectable Targeted Therapy Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Injectable Targeted Therapy Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Injectable Targeted Therapy Product Solution and Service
Table 23. Date of Enter into Injectable Targeted Therapy Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Injectable Targeted Therapy Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Injectable Targeted Therapy Revenue Market Share by Type (2016-2021)
Table 27. Global Injectable Targeted Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Injectable Targeted Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Injectable Targeted Therapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Injectable Targeted Therapy Revenue Market Share by Application (2016-2021)
Table 31. Global Injectable Targeted Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Injectable Targeted Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Injectable Targeted Therapy Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Injectable Targeted Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Injectable Targeted Therapy Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Injectable Targeted Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Injectable Targeted Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Injectable Targeted Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Injectable Targeted Therapy Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Injectable Targeted Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Injectable Targeted Therapy Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Injectable Targeted Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Injectable Targeted Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Injectable Targeted Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Injectable Targeted Therapy Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Injectable Targeted Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Injectable Targeted Therapy Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Injectable Targeted Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Injectable Targeted Therapy Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Injectable Targeted Therapy Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Injectable Targeted Therapy Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Injectable Targeted Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Injectable Targeted Therapy Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Injectable Targeted Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Injectable Targeted Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Injectable Targeted Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Injectable Targeted Therapy Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Injectable Targeted Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Injectable Targeted Therapy Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Injectable Targeted Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Injectable Targeted Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Injectable Targeted Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 63. Novartis Company Details
Table 64. Novartis Business Overview
Table 65. Novartis Injectable Targeted Therapy Product
Table 66. Novartis Revenue in Injectable Targeted Therapy Business (2016-2021) & (US$ Million)
Table 67. Novartis Recent Development
Table 68. Sanofi Company Details
Table 69. Sanofi Business Overview
Table 70. Sanofi Injectable Targeted Therapy Product
Table 71. Sanofi Revenue in Injectable Targeted Therapy Business (2016-2021) & (US$ Million)
Table 72. Sanofi Recent Development
Table 73. GSK Company Details
Table 74. GSK Business Overview
Table 75. GSK Injectable Targeted Therapy Product
Table 76. GSK Revenue in Injectable Targeted Therapy Business (2016-2021) & (US$ Million)
Table 77. GSK Recent Development
Table 78. Bayer Company Details
Table 79. Bayer Business Overview
Table 80. Bayer Injectable Targeted Therapy Product
Table 81. Bayer Revenue in Injectable Targeted Therapy Business (2016-2021) & (US$ Million)
Table 82. Bayer Recent Development
Table 83. Amgen Company Details
Table 84. Amgen Business Overview
Table 85. Amgen Injectable Targeted Therapy Product
Table 86. Amgen Revenue in Injectable Targeted Therapy Business (2016-2021) & (US$ Million)
Table 87. Amgen Recent Development
Table 88. Merck Company Details
Table 89. Merck Business Overview
Table 90. Merck Injectable Targeted Therapy Product
Table 91. Merck Revenue in Injectable Targeted Therapy Business (2016-2021) & (US$ Million)
Table 92. Merck Recent Development
Table 93. AbbiVie Company Details
Table 94. AbbiVie Business Overview
Table 95. AbbiVie Injectable Targeted Therapy Product
Table 96. AbbiVie Revenue in Injectable Targeted Therapy Business (2016-2021) & (US$ Million)
Table 97. AbbiVie Recent Development
Table 98. AstraZeneca Company Details
Table 99. AstraZeneca Business Overview
Table 100. AstraZeneca Revenue in Injectable Targeted Therapy Business (2016-2021) & (US$ Million)
Table 101. AstraZeneca Recent Development
Table 102. Teva Company Details
Table 103. Teva Business Overview
Table 104. Teva Injectable Targeted Therapy Product
Table 105. Teva Revenue in Injectable Targeted Therapy Business (2016-2021) & (US$ Million)
Table 106. Teva Recent Development
Table 107. Roche Company Details
Table 108. Roche Business Overview
Table 109. Roche Injectable Targeted Therapy Product
Table 110. Roche Revenue in Injectable Targeted Therapy Business (2016-2021) & (US$ Million)
Table 111. Roche Recent Development
Table 112. Pfizer Company Details
Table 113. Pfizer Business Overview
Table 114. Pfizer Injectable Targeted Therapy Product
Table 115. Pfizer Revenue in Injectable Targeted Therapy Business (2016-2021) & (US$ Million)
Table 116. Pfizer Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Injectable Targeted Therapy Market Share by Type: 2020 VS 2027
Figure 2. Monoclonal Antibodies Features
Figure 3. Small-Molecules Features
Figure 4. Immunotoxins Features
Figure 5. Others Features
Figure 6. Global Injectable Targeted Therapy Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Homecare Case Studies
Figure 9. Specialty Clinics Case Studies
Figure 10. Others Case Studies
Figure 11. Injectable Targeted Therapy Report Years Considered
Figure 12. Global Injectable Targeted Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Injectable Targeted Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Injectable Targeted Therapy Market Share by Regions: 2020 VS 2027
Figure 15. Global Injectable Targeted Therapy Market Share by Regions (2022-2027)
Figure 16. Global Injectable Targeted Therapy Market Share by Players in 2020
Figure 17. Global Top Injectable Targeted Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Injectable Targeted Therapy as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Injectable Targeted Therapy Revenue in 2020
Figure 19. Global Injectable Targeted Therapy Revenue Market Share by Type (2016-2021)
Figure 20. Global Injectable Targeted Therapy Revenue Market Share by Type (2022-2027)
Figure 21. North America Injectable Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Injectable Targeted Therapy Market Share by Type (2016-2027)
Figure 23. North America Injectable Targeted Therapy Market Share by Application (2016-2027)
Figure 24. North America Injectable Targeted Therapy Market Share by Country (2016-2027)
Figure 25. United States Injectable Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Injectable Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Injectable Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Injectable Targeted Therapy Market Share by Type (2016-2027)
Figure 29. Europe Injectable Targeted Therapy Market Share by Application (2016-2027)
Figure 30. Europe Injectable Targeted Therapy Market Share by Country (2016-2027)
Figure 31. Germany Injectable Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Injectable Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Injectable Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Injectable Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Injectable Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Injectable Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Injectable Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Injectable Targeted Therapy Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Injectable Targeted Therapy Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Injectable Targeted Therapy Market Share by Region (2016-2027)
Figure 41. China Injectable Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Injectable Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Injectable Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Injectable Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Injectable Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Injectable Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Injectable Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Injectable Targeted Therapy Market Share by Type (2016-2027)
Figure 49. Latin America Injectable Targeted Therapy Market Share by Application (2016-2027)
Figure 50. Latin America Injectable Targeted Therapy Market Share by Country (2016-2027)
Figure 51. Mexico Injectable Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Injectable Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Injectable Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Injectable Targeted Therapy Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Injectable Targeted Therapy Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Injectable Targeted Therapy Market Share by Country (2016-2027)
Figure 57. Turkey Injectable Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Injectable Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Injectable Targeted Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Novartis Revenue Growth Rate in Injectable Targeted Therapy Business (2016-2021)
Figure 61. Sanofi Revenue Growth Rate in Injectable Targeted Therapy Business (2016-2021)
Figure 62. GSK Revenue Growth Rate in Injectable Targeted Therapy Business (2016-2021)
Figure 63. Bayer Revenue Growth Rate in Injectable Targeted Therapy Business (2016-2021)
Figure 64. Amgen Revenue Growth Rate in Injectable Targeted Therapy Business (2016-2021)
Figure 65. Merck Revenue Growth Rate in Injectable Targeted Therapy Business (2016-2021)
Figure 66. AbbiVie Revenue Growth Rate in Injectable Targeted Therapy Business (2016-2021)
Figure 67. AstraZeneca Revenue Growth Rate in Injectable Targeted Therapy Business (2016-2021)
Figure 68. Teva Revenue Growth Rate in Injectable Targeted Therapy Business (2016-2021)
Figure 69. Roche Revenue Growth Rate in Injectable Targeted Therapy Business (2016-2021)
Figure 70. Pfizer Revenue Growth Rate in Injectable Targeted Therapy Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

以下、関連資料のご紹介

世界の小分子標的治療市場規模・現状・予測（2021年-2027年）

Global Small Molecule Targeted Therapy Market Size, Status and Forecast 2021-2027
QFJ1-4876 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、小分子標的治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（TKI、マルチターゲット阻害剤、その他）、用途別市場規模（肝臓がん、結腸直腸がん、肺がん、胃がん、乳がん、食道がん、その他）、主要地域別市...

世界のネオアンチゲン標的療法市場規模・現状・予測（2021年-2027年）

Global Neoantigen Targeted Therapies Market Size, Status and Forecast 2021-2027
QFJ1-5264 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、ネオアンチゲン標的療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（単剤療法、併用療法）、用途別市場規模（医療研究機関、病院・クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、...

世界の注射式鎮痛薬市場規模・現状・予測（2021年-2027年）

Global Injectable Pain Medication Market Size, Status and Forecast 2021-2027
QFJ1-4373 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、注射式鎮痛薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（非ステロイド性抗炎症薬（NSAID）、中枢作用性鎮痛薬）、用途別市場規模（病院、クリニック、リカバリーセンター）、主要地域別市場規模（北米、...

世界の高分子注射薬市場規模・現状・予測（2021年-2027年）

Global Large Molecule Injectable Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4411 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、高分子注射薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（静脈注射、筋肉注射、皮下注射）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本...

世界の注射式骨代替物市場規模・現状・予測（2021年-2027年）

Global Injectable Bone Substitute Market Size, Status and Forecast 2021-2027
QFJ1-5213 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、注射式骨代替物の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（天然、合成）、用途別市場規模（病院、クリニック）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、...

世界の注射式しわ治療市場規模・現状・予測（2021年-2027年）

Global Injectable Anti-Wrinkle Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4372 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、注射式しわ治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（筋弛緩薬、ヒアルロン酸リンクルフィラー、合成リンクルフィラー、コラーゲンリンクルフィラー、自己リンクルフィラー）、用途別市場規模（男性用、...

世界の注射式駆虫薬市場規模・現状・予測（2021年-2027年）

Global Injectable Anthelmintic Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4371 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、注射式駆虫薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ベンズイミダゾール、ピペラジン、イミダゾチアゾール、スピロインドール、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、動物用薬...

世界の長時間作用型注射薬市場規模・現状・予測（2021年-2027年）

Global Long-acting Injectable Medications Market Size, Status and Forecast 2021-2027
QFJ1-4439 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、長時間作用型注射薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（第一世代、第二世代）、用途別市場規模（統合失調症、避妊、HIV、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国...

世界の神経調節物質注射市場規模・現状・予測（2021年-2027年）

Global Neuromodulators Injectable Market Size, Status and Forecast 2021-2027
QFJ1-4570 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、神経調節物質注射の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ボツリヌス毒素、ヒアルロン酸、ヒドロキシアパタイトカルシウム、ポリ-L-乳酸、その他）、用途別市場規模（病院、皮膚科クリニック、スパ、エ...

世界の標的バイオマーカー市場規模・現状・予測（2021年-2027年）

Global Targeted Biomarker Market Size, Status and Forecast 2021-2027
QFJ1-4933 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、標的バイオマーカーの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（安全性バイオマーカー、有効性バイオマーカー、検証バイオマーカー）、用途別市場規模（診断開発、創薬・開発、個別化医療、疾病リスク評価、そ...

世界のRNA標的小分子市場規模・現状・予測（2021年-2027年） RNA-targeting small molecules represent a class of small molecules. RNA-targeting small molecules represent a class of small molecules, organic compounds with traditional drug properties that can bind to RNA secondary or tertiary structures and alter translation patterns, localization, and degradati…
世界の小分子標的治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Small Molecule Targeted Therapy Market The global Small Molecule Targeted Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data i…
世界のモノクローナル抗体滅菌注射薬産業調査2019-2025 Monoclonal antibodies are produced through cell division from a single ancestral or parent cell.In 2018, the global Monoclonal Antibodies Sterile Injectable Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been…
世界のモノクローナル抗体滅菌注射薬産業調査2019-2025 Monoclonal antibodies are produced through cell division from a single ancestral or parent cell.In 2018, the global Monoclonal Antibodies Sterile Injectable Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been…
世界の二重特異性モノクローナル抗体市場規模・現状・予測（2021年-2027年） A bispecific antibody (BsAb), or specific monoclonal antibody (BsMAb) is an artificial protein comprised of fragments from two different antibodies. By virtue of the inclusion of two different antigen binding regions, a bispecific antibody is capable of recognizing and binding to two different antig…